Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005.

Yu B, Kline C, Hoare O, Jung J, Knowles T, Ranavaya A, Minturn J, Banerjee A, Leary S, Crotty E, Abdelbaki M, Whipple N, Goldman S, Margol A, Bhatia A, Dababo N, George E, Nabavizadeh A, Pampaloni MH, Inagaki A, Collins S, Chuntova P, Barcova M, Patel TS, Phillips J, Prados M, Molinaro A, Gupta N, Raffel C, Cole K, Kasahara N, Diaz AA, Mueller S

Open source

DOI
10.1158/1078-0432.ccr-24-3721
Published
2025 Aug 14
Container
Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-24-3721,
  title = {Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005.},
  author = {Yu B and Kline C and Hoare O and Jung J and Knowles T and Ranavaya A and Minturn J and Banerjee A and Leary S and Crotty E and Abdelbaki M and Whipple N and Goldman S and Margol A and Bhatia A and Dababo N and George E and Nabavizadeh A and Pampaloni MH and Inagaki A and Collins S and Chuntova P and Barcova M and Patel TS and Phillips J and Prados M and Molinaro A and Gupta N and Raffel C and Cole K and Kasahara N and Diaz AA and Mueller S},
  year = {2025},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-24-3721},
  url = {https://doi.org/10.1158/1078-0432.ccr-24-3721}
}

RIS

TY  - JOUR
TI  - Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005.
AU  - Yu B
AU  - Kline C
AU  - Hoare O
AU  - Jung J
AU  - Knowles T
AU  - Ranavaya A
AU  - Minturn J
AU  - Banerjee A
AU  - Leary S
AU  - Crotty E
AU  - Abdelbaki M
AU  - Whipple N
AU  - Goldman S
AU  - Margol A
AU  - Bhatia A
AU  - Dababo N
AU  - George E
AU  - Nabavizadeh A
AU  - Pampaloni MH
AU  - Inagaki A
AU  - Collins S
AU  - Chuntova P
AU  - Barcova M
AU  - Patel TS
AU  - Phillips J
AU  - Prados M
AU  - Molinaro A
AU  - Gupta N
AU  - Raffel C
AU  - Cole K
AU  - Kasahara N
AU  - Diaz AA
AU  - Mueller S
PY  - 2025
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-24-3721
UR  - https://doi.org/10.1158/1078-0432.ccr-24-3721
ER  - 

APA

B, Y., C, K., O, H., J, J., T, K., A, R., J, M., A, B., S, L., E, C., M, A., N, W., S, G., A, M., A, B., N, D., E, G., A, N., MH, P., A, I., S, C., P, C., M, B., TS, P., J, P., M, P., A, M., N, G., C, R., K, C., N, K., AA, D., & S, M. (2025). Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-3721

Source records